Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8931-8940 Newer>

Pharmaceutical Executive September 1, 2014 William Looney	13 Years Right Pharm Exec's latest Industry Audit sticks to the series' longtime standard of emphasizing transparent indicators of shareholder value.
Pharmaceutical Executive September 1, 2014	Country Report: Spain Spain's recession-battered pharma sector adapts to a changing market environment and repositions itself for a return to healthy growth through expanding opportunities abroad.
Pharmaceutical Executive September 1, 2014	Peril, Not Progress on Transatlantic Trade Deal Pharma hopes for a deal are fading as the once-hot TTIP talks seem to be on the fizzle in Europe.
Pharmaceutical Executive September 1, 2014 Pierre Morgon	Medical Affairs: From Info Gatekeeper to Legitimate Value Driver The role of pharma medical affairs teams is taking on greater importance in the value chain.
Pharmaceutical Executive September 1, 2014 Julian Upton	OTC Drug Advertising: Alfred Hitchcock Style The legendary director's on-screen attitude to his TV show's sponsor, Bristol-Myers, caused some consternation until the drugmaker saw the results.
Pharmaceutical Executive September 1, 2014 Jill Wechsler	Pharma Battles Hospitals Over 340B Pricing Expansion of drug discount program ignites lawsuits, policy disputes.
Chemistry World September 5, 2014 Emma Stoye	Servier to appear in adverts over lack of transparency European pharma group Servier Laboratories is to appear in adverts for breaching the Association of the British Pharma Industry code of practice by failing to publish clinical trial results.
Information Today September 4, 2014	SAGE Plans Journal for Asian and Pacific Islander Healthcare SAGE Publications announced Asian/Pacific Island Nursing, its new open access journal.
Information Today September 4, 2014	EBSCO Health Now Offers Oncology Resources EBSCO Health and the National Comprehensive Cancer Network signed an agreement that allows information from NCCN to be summarized and made available through DynaMed, EBSCO Health's clinical reference tool.
Chemistry World September 3, 2014 Phillip Broadwith	Novo Nordisk quits inflammation R&D and cuts jobs Novo Nordisk is terminating its inflammatory disease R&D programs after the company's leading rheumatoid arthritis drug candidate failed in clinical trials.
<Older 8931-8940 Newer> Return to current articles.